RESUMEN
CCR-5 is a major cellular coreceptor for R5 strains of HIV-1. Individuals carrying a homozygous 32-base-pair deletion in this gene are apparently healthy and are relatively resistant to HIV-1 infection. Since CCR5 appears to be dispensable for the host, but important for initial HIV-1 infection, CCR5 mRNA is an excellent therapeutic target for inhibiting HIV-1 replication via ribozyme knockout. We report here that hairpin ribozymes are able to reduce cellular CCR5 mRNA and cell surface CCR5 when stably introduced into PM1 cells by transduction with recombinant adenoassociated viral vector. The ribozymes effectively protect the cells from infection by R5 HIV-1 strains or non-syncytium-inducing clinical isolates commensurate with a reduction in CCR5 mRNA. These results suggest a novel gene therapy approach to preventing or slowing the disease progression of HIV-1 infection.
Asunto(s)
Antagonistas de los Receptores CCR5 , Terapia Genética , VIH-1/efectos de los fármacos , ARN Catalítico/genética , Línea Celular , VIH-1/metabolismo , Humanos , Cinética , Fusión de Membrana/efectos de los fármacos , Conformación de Ácido Nucleico , ARN Catalítico/química , ARN Catalítico/farmacología , ARN Mensajero/antagonistas & inhibidores , ARN Mensajero/metabolismo , Receptores CCR5/genética , Receptores CCR5/metabolismoRESUMEN
Recombinant adenoassociated virus (rAAV) type 2 vectors have been used to transduce a wide variety of cell types, including hematopoietic progenitor cells. For in vivo gene transfer, it is desirable to have an rAAV vector that specifically transduces selected target cells. As a first step toward generating an rAAV vector capable of targeting delivery in vivo, we have engineered a chimeric protein combining the AAV capsid protein and the variable region of a single-chain antibody against human CD34 molecules, a cell surface marker for hematopoietic stem/progenitor cells. Inclusion of the chimeric CD34 single-chain antibody-AAV capsid proteins within an rAAV virion significantly increased the preferential infectivity of rAAV for the CD34+ human myoleukemia cell line KG-1, which is normally refractory to rAAV transduction. Antibodies against the single-chain antibody and the CD34 protein blocked this transduction. This chimeric vector represents a significant improvement in the host range of rAAV and the first step toward specific gene delivery by rAAV vectors to cells of choice, in this case, hematopoietic progenitor cells, for the treatment of human disease.
Asunto(s)
Antígenos CD34 , Dependovirus/genética , Marcación de Gen/métodos , Vectores Genéticos/genética , Región Variable de Inmunoglobulina/genética , Anticuerpos Antiidiotipos , Anticuerpos Bloqueadores , Anticuerpos Monoclonales , Antígenos CD34/inmunología , Antígenos CD34/metabolismo , Unión Competitiva , Biomarcadores , Cápside/genética , Clonación Molecular , Dependovirus/aislamiento & purificación , Terapia Genética/métodos , Células HeLa , Células Madre Hematopoyéticas , Humanos , Leucemia Mieloide Aguda , ARN Mensajero/biosíntesis , ARN Viral/biosíntesis , Proteínas Recombinantes de Fusión , Células Tumorales Cultivadas , Proteínas Virales/biosíntesis , ViriónRESUMEN
The human immunodeficiency virus type 1 strain MN (HIV-1MN) principal neutralizing determinant (PND, V3 loop) was introduced into infectious molecular clones HIV-2KR and simian immunodeficiency virus mm239 (SIVmm239) by hybridization PCR, replacing the corresponding HIV-2 or SIV envelope cysteine loops with the HIV-1 coding sequence. The HIV-2 chimera (HIV-2KR-MNV3) was found to be capable of infecting a number of T-cell lymphoblastic cell lines as well as primary peripheral blood mononuclear cells. In contrast, the SIV chimera (SIV239MNV3) was not replication competent. Envelope produced by HIV-2KR-MNV3 but not the parental HIV-2KR was recognized by V3-specific and HIV-1-specific polyclonal antisera in radioimmunoprecipitation assays. HIV-2-specific antisera recognized both the chimeric and parental virus but not HIV-1MN. The chimeric HIV-2KR-MNV3 virus proved to be exquisitely susceptible to neutralization by HIV-1-specific and V3-specific antisera, suggesting the potential for use in animal models designed to test HIV-1 vaccine candidates which target the PND.
Asunto(s)
Productos del Gen env/biosíntesis , Productos del Gen env/inmunología , VIH-1/fisiología , VIH-2/fisiología , Linfocitos T/virología , Replicación Viral , Secuencia de Bases , Línea Celular , Quimera , Cisteína , Cartilla de ADN , Productos del Gen env/genética , VIH-1/genética , VIH-2/genética , VIH-2/patogenicidad , Humanos , Cinética , Datos de Secuencia Molecular , Mutagénesis , Reacción en Cadena de la Polimerasa , Ensayo de Radioinmunoprecipitación/métodos , Virus de la Inmunodeficiencia de los Simios/fisiología , Linfocitos T/inmunología , Células Tumorales CultivadasRESUMEN
One of the principal problems with using recombinant adeno-associated virus vectors (rAAV) as vehicles for gene delivery has been the difficulty in obtaining high-titer virus stocks after the initial transfection into producer cells. In this report we describe a method for transfecting cells at extremely high efficiency with rAAV vector DNA and complementation plasmid while simultaneously infecting those cells with replication competent adenovirus using adenovirus-polylysine-DNA complexes. We further show that this technique results in an increase in rAAV transducing titer by two orders of magnitude over what is typically achieved by standard calcium phosphate transfection.
Asunto(s)
Adenoviridae/genética , Dependovirus/genética , Vectores Genéticos , VIH-1/genética , ARN Catalítico/biosíntesis , Transfección/métodos , Adenoviridae/fisiología , ADN Viral/administración & dosificación , ADN Viral/metabolismo , Portadores de Fármacos , Prueba de Complementación Genética , Células HeLa , Humanos , Plásmidos , Polilisina/administración & dosificación , ARN Catalítico/genética , Recombinación Genética , Replicación ViralRESUMEN
CHO-K1 cells, wild type (WT), grow in a defined medium with insulin as the only essential hormone. When starved for insulin, these cells accumulate in G0/G1 stage. Insulin binding to its receptor stimulates DNA synthesis and cell division and induces an increase in abundance of mRNA for c-fos, c-jun, Krox-20, Krox-24 (zif/268), fra-1, jun-B, c-myc, and JE. The kinetics of induction of these genes are similar to that shown with serum induction of 3T3. These genes show maximum stimulation at insulin concentrations of 20, 160, or 320 ng/ml and their expression is inhibited at higher concentrations. The addition of cycloheximide results in superinduction. The WT and insulin-independent mutants show no detectable signal for KC, fos-b, or nur77 and no increase over the basal level of pI-15, probably eliminating these genes as participants in the insulin mitogenic signal. These mutants synthesize DNA in the absence of insulin at rates that vary from 4 to 12 times that of the quiescent (insulin unstimulated) WT and are further inducible by insulin. The mutants have "constitutive" levels of Krox-24 (zif/268), fra-1, jun-B, c-myc, and JE (INS-type 2 genes) mRNAs that vary from mutant to mutant, reaching a maximum of an 8-fold increase for fra-1 and JE over the quiescent WT levels. There were no detectable levels of mRNA for genes c-fos and Krox-20 and no increase in level of mRNA for c-jun (INS-type 1 genes) as compared to the quiescent WT. Thus, although these INS-type 1 and type 2 genes may be involved in the full insulin mitogenic signal, the constitutive up-regulation of only genes in INS-type 2 is sufficient for insulin-independent DNA synthesis and cell division. Analysis of hybrids constructed between WT and mutant 27 indicate that the mutant phenotype is recessive, pointing to the existence of a regulatory gene producing a negative regulator.
Asunto(s)
Ciclo Celular , Insulina/fisiología , Receptor de Insulina/fisiología , Animales , Northern Blotting , Línea Celular , Quimiocina CCL2 , Factores Quimiotácticos/genética , Cricetinae , Cricetulus , Cicloheximida/farmacología , ADN/biosíntesis , Proteínas de Unión al ADN/genética , Femenino , Expresión Génica/efectos de los fármacos , Genes Recesivos , Ovario , Proteínas Proto-Oncogénicas/genética , Proteínas Proto-Oncogénicas c-fos , Proteínas Proto-Oncogénicas c-jun , Proteínas Proto-Oncogénicas c-myc/genética , ARN Mensajero/genética , Factores de Transcripción/genéticaRESUMEN
Insulin is the only hormone required for continued growth of Chinese hamster ovary CHO-K1 cells in the defined medium M-F12. When CHO-K1 cells are incubated in M-F12 without insulin for 48-72 hr, the cells accumulate in G1. In response to physiological concentrations of insulin an 18-fold increase in rate of DNA synthesis occurs due to cells entering S phase after an 8- to 10-hr lag; cell division begins after 24 hr. The inhibitory effect of actinomycin D and 5,6-dichlorobenzimidazole riboside indicates that RNA synthesis is required for progression to S phase. CHO-K1 cells possess insulin receptors, and the insulin effect results from insulin binding to its own receptor: (i) Binding occurs at physiological insulin concentrations with a half-maximal stimulation at approximately 14 ng/ml. (ii) At insulin concentrations used, insulin-like growth factor I and II (IGF-I and IGF-II) have little or no effect. (iii) Scatchard analysis of 125I-labeled insulin binding shows the curvilinear response typical of insulin. (iv) The Kd for the so-called high-affinity binding site and the Ke are characteristic of the insulin receptor. (v) At the minimal insulin concentrations that stimulate growth, IGF-I and IGF-II compete poorly with insulin for insulin binding, insulin competes poorly with IGF-I for IGF-I binding, and affinity labeling with 125I-labeled insulin identifies a polypeptide (Mr = 125,000) typical of the alpha subunit of the insulin receptor.
Asunto(s)
Ciclo Celular/efectos de los fármacos , Replicación del ADN/efectos de los fármacos , Insulina/farmacología , Receptor de Insulina/fisiología , Animales , Unión Competitiva , División Celular/efectos de los fármacos , Línea Celular , Cricetinae , Cricetulus , Dactinomicina/farmacología , Femenino , Insulina/metabolismo , Interfase/efectos de los fármacos , Cinética , Mitógenos , Ovario , Somatomedinas/farmacologíaRESUMEN
Insulin, FeSO4, or transferrin are major requirements together with HEPES buffer and selenium for the growth of CHO-K1 (CCL 61) in a modified F12 medium (M-F12). Insulin stimulates growth at 1 ng/ml to 10 micrograms/ml. In the defined medium minus insulin, CHO-K1 grows slowly as elongated, elliptical cells in parallel arrays typical of normal diploid fibroblasts in contrast to round-to-cuboid cells in loosely overlapping arrays in the presence of serum or insulin. During prolonged incubation in the absence of insulin the cells gather up into a large spherical cluster of viable cells. Insulin "independent" mutants have been isolated whose growth rate during exponential phase in the absence of insulin (48 h to 84 or 96 hrs) is 2.7 to 3.6 times that of the parental culture. Insulin stimulates the growth of these variants only during the first 48 h and is inhibitory at 50 to 500 ng/ml during the exponential phase. Insulin induction of the A system of amino acid transport occurs in about 8 h and requires both protein and RNA synthesis.